New Call for Abstracts and Registration [International Conference on AIDS (8th: 1992: Amsterdam, Netherlands)]

436 gay men, prognosis
437 gay men, progression
438 gay men, psychosocial
439 gay men, seroconversion
440 gay men, SEE sexual behavior
441 gay men, subgroups
442 gay men, symptoms
443 gay men, other
444 gene products, 26kD
445 gene products, biochemical
processing
446 gene products, biochemical
synthesis
447 gene products, core proteins
448 gene products, endonuclease
449 gene products, env
450 gene products, gag
451 gene products, HIV
452 gene products, SEE HIV antigen
453 gene products, nef
454 gene products, pol
455 gene products, SEE protease
456 gene products, SEE regulation
457 gene products, rev
458 gene products, SEE reverse
459 gene products, transcriptase
460 gene products, tat
461 gene products, vif
462 gene products, vpr
463 gene products, vpu
464 gene products, vpx
465 gene products, other
466 general population, prevalence
467 genome
468 genome, new genes
469 genomic diversity
470 geographical regions SEE also
gay men, IVDU, prostitutes,
developing countries, and end
of list
471 geographical regions, AFRICA
472 Africa, general
473 Algeria
474 Angola
475 Botswana
476 Burkina Faso
477 Cameroon
478 Central African Republic
479 Comoro Islands
480 Congo
481 East Africa
482 Egypt
483 Ethiopia
484 Gambia
485 Ghana
486 Guinea Bissau
487 Ivory Coast
488 Kenya
489 Liberia
490 Madagascar
491 Malawi

492 Mali
493 Mozambique

494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511

Nigeria
Rwanda
Senegal
Sierra Leone
Somalia
South Africa
Sudan
Tanzania
Tunisia
Uganda
West Africa
Zaire
Zambia
Zimbabwe
geographical regions, ASIA
China
Hong Kong
India

554 Norway
555 Paris
556 Poland
557 Portugal
558 Sardinia
559 Scotland
560 Sicily
561 Spain
562 Sweden
563 Switzerland
564 Turkey
565 United Kingdom
566 USSR
567 West Germany
568 Yugoslavia
569 geographical regions,
MIDDLE EAST
570 Iran

613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637

GM-CSF
gonadotropins
gp 120, activation
gp 120, binding
gp 120, defective
gp 120, glycosylation
gp 120, human monoclonal
gp 120, suppression
gp 120, toxicity
gp 120, other
gp 160
gp 41, SEE also epitope analysis
group support
Guillain-Barre syndrome
gynecology
hair loss
HBV (hepatitis B virus)
HBV, vaccination
HDV (hepatitis delta virus)
health beliefs
health care, long term care
health care, cost, SEE cost
health care, organization
health care personnel, behavior
health care personnel, dentists

512 Indonesia
513 Japan
514 Nepal
515 New Guinea
516 Pakistan
517 Philippines
518 Sri Lanka
519 Taiwan
520 Thailand
521 geographical regions,
AUSTRALIA/NEW ZEALAND
522 geographical regions,
CARIBBEAN
523 Bahamas
524 Barbados
525 Bermuda
526 Caribbean, general
527 Cuba
528 Dominican Republic
529 Haiti
530 Jamaica
531 Martinique
532 Puerto Rico
533 Trinidad
534 geographical regions,
CENTRAL AMERICA
535 Costa Rica
536 El Salvador
537 Guatemala
538 Honduras
539 Nicaragua
540 Panama
541 geographical regions, EUROPE

571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612

Israel
Jordan
Kuwait
Saudi Arabia
geographical regions,
NORTH AMERICA
Alaska
Boston
California
Canada
Chicago
Los Angeles
Mexico
Mexico City
Miami
Montreal
New York City
New York State
Ontario
Quebec Province
San Francisco
Toronto
United States
geographical regions,
SOUTH AMERICA
Argentina
Bolivia
Brazil
Buenos Aires
Chile
Colombia
Ecuador
Peru
Rio de Janeiro
Sao Paulo
South America, general
Surinam
germanium-organic compounds
gloves, SEE also health care
personnel
GLQ 223, SEE compound Q
glutathione
glycopeptides
glycosylation inhibitors
glycyrrhizin

638 health care personnel,
needle sticks
639 health care personnel, nurses
640 health care personnel, physicians
641 health care personnel,
prevalence
642 health care personnel, risks to
643 health care personnel, stress
644 health care personnel,
traditional healers
645 health care personnel, training
646 health care personnel, other
647 hearing loss
648 heart, endocarditis
649 heart, myocarditis
650 heart, other
651 heat treated factor VIII
652 helicobacter infections
653 hematological abnormalities
654 hematopoiesis
655 hemodialysis
656 hemophilia, children, SEE
children
657 hemophilia, coinfections
658 hemophilia, education
659 hemophilia, epidemiology
660 hemophilia, immunology
661 hemophilia, neurology
662 hemophilia, prevalence
663 hemophilia, prevention
664 hemophilia, prognosis
665 hemophilia, progression
666 hemophilia, psychosocial
667 hemophilia, seroconversion
668 hemophilia, sexual transmission
669 hemophilia, zidovudine
metabolism
670 hemophilia, other

542
543
544
545
546
547
548
549
550
551
552
553

Belgium
Bulgaria
Czechoslovakia
Denmark
Europe, general
Finland
France
French overseas territories
Greece
Hungary
Italy
Netherlands

xxii